Cyriac Chemplavil, MD
Pulmonary Disease · Henderson, NVNPI 1689853947
Payments from drug & device makers
Across 798 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- GSK$2K
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Actelion Pharmaceuticals US, Inc.$1K
- Mylan Specialty L.p.$1K
- plus $7K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 152 | $3,891 |
| GSK | 125 | $2,345 |
| Sanofi | 58 | $1,512 |
| Regeneron Healthcare Solutions, Inc. | 55 | $1,449 |
| Actelion Pharmaceuticals US, Inc. | 53 | $1,291 |
| Mylan Specialty L.p. | 43 | $1,031 |
| Boehringer Ingelheim | 46 | $957 |
| Grifols USA, LLC | 27 | $627 |
| Harmony Biosciences LLC | 16 | $423 |
| Covis Pharma GmbH | 27 | $385 |
| Insmed, Inc. | 20 | $375 |
| Paratek Pharmaceuticals, Inc. | 20 | $354 |
| Merck | 17 | $348 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $304 |
| Mallinckrodt Hospital Products Inc. | 13 | $304 |
| Philips North America LLC | 13 | $271 |
| United Therapeutics Corporation | 12 | $244 |
| Sanofi-aventis U.S. LLC | 3 | $198 |
| Verona Pharma, Inc. | 6 | $188 |
| Axsome Therapeutics, Inc. | 8 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $182 |
| Jazz Pharmaceuticals Inc. | 8 | $156 |
| Teva Pharmaceuticals USA, Inc. | 8 | $151 |
| Circassia Inc. | 11 | $144 |
| Genentech USA, Inc. | 8 | $127 |
| Baxter Healthcare | 5 | $114 |
| Gilead | 5 | $90 |
| Amgen | 4 | $85 |
| Vifor Pharma, Inc. | 3 | $66 |
| Viatris Specialty LLC | 2 | $58 |
| Melinta Therapeutics, LLC | 3 | $58 |
| Bayer | 2 | $53 |
| Pulmonx Corporation | 2 | $46 |
| Shionogi Inc | 1 | $22 |
| Breas Medical, Inc. | 1 | $21 |
| CSL Behring | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $14 |
How this compares
$18,088 in reported general payments places this provider in the 85th percentile of 84 pulmonary disease providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Henderson
- Thomson ChemplavilHenderson$17K
- Sapna BhatiaHenderson$10K
- Rajiv AmesurHenderson$9K
- Robert WillsHenderson$8K
- Syed AkbarullahHenderson$4K
- Michelle DanielianHenderson$2K
- Xenia SchneiderHenderson$805
- Hrishikesh KulkarniHenderson$606
- Kenneth MooneyHenderson$500
- Naresh SinghLas Vegas$711K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.